[View original text]

On 24th of Sep, AIDOT , a medical AI company, announced that it has signed a contract with Korea Investment & Securities as a supervisor for listing on the KOSDAQ.

AIDOT has developed and completed the world's first cervical cancer artificial intelligence diagnosis system "Cerviray" and "SONO dot AI," a pre-stroke carotid diagnosis system, and is currently promoting commercialization.

In addition, pipelines such as microbiome-based alcoholic liver disease diagnosis systems and artificial intelligence-based diagnostic systems in all fields of digestive organs are 

being firmly established.

Jaehoon Jeong, CEO of AIDOT said, "We are pursuing global sales performance-based KOSDAQ listing with licensing and unrivaled technology, and we are ahead of global competitors such as Israel by establishing and completing a business model that generates profits from examinations rather than supplying one-time artificial intelligence medical solutions."

Also said, "This KOSDAQ listing contract with Korea Investment & Securities is based on close business verification and technology verification to move beyond Series A investment to become a global company, and will focus on pioneering new ways for AI healthcare solutions to make sales and maximize profits."

24th. Sep. 2021 / Korea Economy TV